David Berman
Chief Tech/Sci/R&D Officer chez IMMUNOCORE HOLDINGS PLC
Fortune : - $ au 31/03/2024
Profil
David Berman is currently the Head of Research & Development at Immunocore Holdings Plc.
Prior to this, he was the Head of Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015, the Head of Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and the Head of Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018.
Berman received his undergraduate degree from Massachusetts Institute of Technology and his graduate and doctorate degrees from The University of Texas Southwestern Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 28/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Berman
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Anciens postes connus de David Berman
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2018 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2015 |
Formation de David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
